Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction


Por: Borras, E, Urbiztondo, L, Carmona, G, Jane, M, Barrabeig, I, Sala, MR, Balana, JPJ, Company, M, Parron, I, Godoy, P, Rius, C, Soldevila, N, Cabezas, C, Dominguez, A, Alseda, M, Alvarez, J, Arias, C, Balana, PJ, Camps, N, Carol, M, Farras, J, Ferrus, G, Follia, N, Martinez, A, Minguell, S, Planas, C, Rovira, A, Sala, MR, Torres, J, Manzanares, S

Publicada: 21 feb 2019
Resumen:
Hepatitis B is a viral disease of global importance. In Catalonia in the 1980s, the seroepidemiological pattern of HBV infection was low-intermediate. In 1990, the Expert Committee on Vaccinations of the Department of Health of the Generalitat of Catalonia evaluated the systematic introduction of hepatitis B vaccination in preadolescents, maintaining the vaccination of risk groups. The objective of this study was to estimate the effectiveness and impact of the systematic hepatitis B vaccination programme in preadolescents in Catalonia 21 years after its introduction. A retrospective cohort study was conducted, comparing the disease incidence in vaccinated and unvaccinated cohorts. Cases of hepatitis B were defined as those reported by the General Subdirectorate of Surveillance and Response to Public Health Emergencies between 2000 and 2014. The incidence rate was 2.5 per 100,000 persons in 1991 and 1.2 per 100,000 persons in 2014, a reduction of 52%. During the study period, 388 cases of hepatitis B infection were notified, of which three were classified as vaccine failures. Vaccine effectiveness was 99.30% (95% CI: 97.83-99.78) and the population prevented fraction in the cohorts of preadolescents studied was 64.56% (95% CI: 60.45-68.66). The effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia is high, with the consequent benefits for the population. (C) 2019 Published by Elsevier Ltd.

Filiaciones:
Borras, E:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Univ Barcelona, Dept Med, Barcelona, Spain

 Agencia Salut Publ Catalunya, Barcelona, Spain

Urbiztondo, L:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

 Agencia Salut Publ Catalunya, Barcelona, Spain

Carmona, G:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

 Agencia Salut Publ Catalunya, Barcelona, Spain

Jane, M:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Agencia Salut Publ Catalunya, Barcelona, Spain

Barrabeig, I:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Agencia Salut Publ Catalunya, Barcelona, Spain

Sala, MR:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

Balana, JPJ:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

Company, M:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

 Agencia Salut Publ Catalunya, Barcelona, Spain

Parron, I:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

 Agencia Salut Publ Catalunya, Barcelona, Spain

Godoy, P:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Agencia Salut Publ Catalunya, Barcelona, Spain

Rius, C:
 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Agencia Salut Publ Barcelona, Barcelona, Spain

Soldevila, N:
 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Univ Barcelona, Dept Med, Barcelona, Spain

 Univ Barcelona, Barcelona, Spain

Cabezas, C:
 Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain

 Agencia Salut Publ Catalunya, Barcelona, Spain

Dominguez, A:
 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Univ Barcelona, Dept Med, Barcelona, Spain

 Univ Barcelona, Barcelona, Spain

Alseda, M:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Alvarez, J:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Arias, C:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Balana, PJ:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Camps, N:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Carol, M:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Farras, J:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Ferrus, G:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Follia, N:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Martinez, A:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Minguell, S:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Planas, C:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Rovira, A:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Sala, MR:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Torres, J:
 Agencia Salut Publ Catalunya, Barcelona, Spain

Manzanares, S:
 Agencia Salut Publ Barcelona, Barcelona, Spain
ISSN: 0264410X





VACCINE
Editorial
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 37 Número: 9
Páginas: 1137-1141
WOS Id: 000459841000002
ID de PubMed: 30709729

MÉTRICAS